Tranexamic acid is associated with decreased transfusion, hospital length of stay, and hospital cost in simultaneous bilateral total knee arthroplasty
Open Access
- 1 August 2021
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 21 (4) , 471-476
Abstract
Tranexamic acid (TXA) reduces blood loss and transfusion rates in unilateral total knee arthroplasty (TKA), but there is limited data regarding its efficacy in bilateral TKA. This study reports the impact TXA has on clinical outcomes and hospital cost of care in simultaneous, primary bilateral TKA. The 449 patients were retrospectively reviewed. Primary outcomes included the rates of allogeneic and autologous blood transfusion. Secondary outcomes included hospital length of stay (HLOS), post-hospital discharge disposition, 30-day thromboembolic events (TEE), and mean hospital cost of care. Total direct medical costs were obtained from an institutional research database and adjusted to nationally representative unit costs in 2013 inflation-adjusted dollars. Our study revealed that in patients undergoing simultaneous bilateral TKA, TXA use was associated with reduced allogeneic (OR 0.181, 95% CI 0.090-0.366, p < 0.001) and combined allogeneic and autologous transfusion rates (OR 0.451, 95% CI 0.235-0.865, p = 0.017). TXA was associated with a HLOS reduction of 0.9 days (β-coefficient −0.582, 95% CI −1.008-−0.156, p = 0.008), an increased likelihood of hospital discharge over skilled nursing facility (SNF) (OR 2.25, 95% CI 1.117-4.531, p = 0.023) and reduced total hospital cost of care by 6.45% (p < 0.001), room and board costs by 11.76% (p < 0.001), and transfusion costs by 81.65% (p < 0.001). In conclusion, TXA use in bilateral TKA is associated with lower blood transfusion rates, reduced hospital length of stay, reduced cost of hospital care and skilled nursing facility avoidance.Keywords
This publication has 30 references indexed in Scilit:
- Evaluation of the Efficacy and Safety of Tranexamic Acid for Reducing Blood Loss in Bilateral Total Knee ArthroplastyThe Journal of Arthroplasty, 2014
- Simultaneous Bilateral Computer Assisted Total Knee Arthroplasty: The Effect of Intravenous or Intraarticular Tranexamic AcidThe Journal of Arthroplasty, 2013
- Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Hip ReplacementJournal of Bone and Joint Surgery, 2013
- Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Knee ReplacementJournal of Bone and Joint Surgery, 2013
- Economic Impact of Tranexamic Acid in Healthy Patients Undergoing Primary Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2013
- Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood‐saving protocol: a randomized controlled trialKnee Surgery, Sports Traumatology, Arthroscopy, 2013
- Effectiveness and Safety of Tranexamic Acid in Reducing Blood Loss in Total Knee ArthroplastyJournal of Bone and Joint Surgery, 2012
- Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stageIndian Journal of Orthopaedics, 2011
- Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trialsThrombosis Research, 2009
- Exact Calculations of Average Power for the Benjamini-Hochberg ProcedureThe International Journal of Biostatistics, 2008